Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Todd

Showing results (651-660 of 719) with videos related to

Pageof 72
Sort By:
The Lancet. HIV|February 4, 2021
HIV clinic-based buprenorphine plus naloxone versus referral for methadone maintenance therapy for treatment of opioid use disorder in HIV clinics in Vietnam (BRAVO): an open-label, randomised, non-inferiority trialP Todd Korthuis, Caroline King, Ryan R Cook, et al.
Harm Reduction Journal|July 11, 2022
"It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supplySarah S Shin, Kate LaForge, Erin Stack, et al.
Drug and Alcohol Dependence|September 11, 2021
Adjunct interventions to standard medical management of buprenorphine in outpatient settings: A systematic review of the evidenceJessica J Wyse, Benjamin J Morasco, Jacob Dougherty, et al.
Drug and Alcohol Dependence|April 6, 2024
Correlates of overdose among 2711 people who use drugs and live in 7 rural US sitesFadanelli Monica M, Livingston Melvin Doug, Friedmann Peter, et al.
Journal of Neurotrauma|February 15, 2020
Modulation of Post-Traumatic Immune Response Using the IL-1 Receptor Antagonist Anakinra for Improved Visual OutcomesLucy P Evans, Addison W Woll, Shu Wu, et al.
Oral Oncology|October 11, 2014
Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individualsDaniel C Beachler, Alison G Abraham, Michael J Silverberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2016
Healthcare Coverage for HIV Provider Visits Before and After Implementation of the Affordable Care ActStephen A Berry, John A Fleishman, Baligh R Yehia, et al.
Journal of Substance Abuse Treatment|June 15, 2021
Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIVAmy J Kennedy, Kathleen A McGinnis, Jessica S Merlin, et al.
Cell|May 20, 2009
Protein architecture of the human kinetochore microtubule attachment siteXiaohu Wan, Ryan P O'Quinn, Heather L Pierce, et al.
Addiction Science & Clinical Practice|April 10, 2024
Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorderGavin Bart, P Todd Korthuis, Julie M Donohue, et al.
Pageof 72

Showing results (651-660 of 719) with videos related to

Sort By:
Pageof 72
The Lancet. HIV|February 4, 2021
HIV clinic-based buprenorphine plus naloxone versus referral for methadone maintenance therapy for treatment of opioid use disorder in HIV clinics in Vietnam (BRAVO): an open-label, randomised, non-inferiority trialP Todd Korthuis, Caroline King, Ryan R Cook, et al.
Harm Reduction Journal|July 11, 2022
"It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supplySarah S Shin, Kate LaForge, Erin Stack, et al.
Drug and Alcohol Dependence|September 11, 2021
Adjunct interventions to standard medical management of buprenorphine in outpatient settings: A systematic review of the evidenceJessica J Wyse, Benjamin J Morasco, Jacob Dougherty, et al.
Drug and Alcohol Dependence|April 6, 2024
Correlates of overdose among 2711 people who use drugs and live in 7 rural US sitesFadanelli Monica M, Livingston Melvin Doug, Friedmann Peter, et al.
Journal of Neurotrauma|February 15, 2020
Modulation of Post-Traumatic Immune Response Using the IL-1 Receptor Antagonist Anakinra for Improved Visual OutcomesLucy P Evans, Addison W Woll, Shu Wu, et al.
Oral Oncology|October 11, 2014
Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individualsDaniel C Beachler, Alison G Abraham, Michael J Silverberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2016
Healthcare Coverage for HIV Provider Visits Before and After Implementation of the Affordable Care ActStephen A Berry, John A Fleishman, Baligh R Yehia, et al.
Journal of Substance Abuse Treatment|June 15, 2021
Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIVAmy J Kennedy, Kathleen A McGinnis, Jessica S Merlin, et al.
Cell|May 20, 2009
Protein architecture of the human kinetochore microtubule attachment siteXiaohu Wan, Ryan P O'Quinn, Heather L Pierce, et al.
Addiction Science & Clinical Practice|April 10, 2024
Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorderGavin Bart, P Todd Korthuis, Julie M Donohue, et al.
Pageof 72